Abic Biological Laboratories Teva Ltd.
Records under this name other than patents Abic Biological Laboratories Teva Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Abic Biological Laboratories Teva Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,968,695 | Nucleic acids encoding recombinant 56 and 82 kDa antigens from gametocytes of Eimeria maxima and their uses Formerly held Lapsed on the fee record Ended Jun 28, 2019 · USPTO record | Lapsed on the fee record | Ended Jun 28, 2019 | USPTO record |
| US 7,858,766 | Subunits of the adenovirus fiber protein and uses thereof as vaccines Formerly held Lapsed on the fee record Ended Dec 28, 2014 · USPTO record | Lapsed on the fee record | Ended Dec 28, 2014 | USPTO record |
| US 7,462,707 | Nucleic acids encoding a recombinant 250 kDa antigen from sporozoites/merozoites of Eimeria maxima and their uses Formerly held Lapsed on the fee record Ended Dec 9, 2012 · USPTO record | Lapsed on the fee record | Ended Dec 9, 2012 | USPTO record |
| US 7,423,137 | Nucleic acids encoding recombinant 56 and 82 kDa antigens from gametocytes of Eimeria maxima and their uses Formerly held Lapsed on the fee record Ended Sep 9, 2012 · USPTO record | Lapsed on the fee record | Ended Sep 9, 2012 | USPTO record |
| US 5,496,550 | Method of reducing the output of Eimeria oocysts from a newborn chick Term ended Term ended no later than Mar 5, 2016 · Low confidence | Term ended | Term ended no later than Mar 5, 2016 | Low confidence |
| US 5,932,225 | Vaccine comprising eimeria spp. gametocyte antigen Term ended Term ended no later than Aug 3, 2019 · Low confidence | Term ended | Term ended no later than Aug 3, 2019 | Low confidence |